Correlation between radiation dose to 18F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1185-1191

  Rose, Brent S ^a   Liang, Yun ^a   Lau, Steven K ^a   Jensen, Lindsay G ^a   Yashar, Catheryn M ^a   Hoh, Carl K ^a   Mell, Loren K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

18F fluorodeoxyglucose positron emission tomography; Bone marrow; Cervical cancer; Hematologic toxicity

Indexed keywords

BONE MARROW; CERVICAL CANCERS; CONCURRENT CISPLATIN; DOSE-VOLUME; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; HEMATOLOGIC TOXICITY; INTENSITY MODULATED RADIATION THERAPY; LINEAR MODELING; MEAN DOSE; STANDARDIZED UPTAKE VALUES; WHITE BLOOD CELLS;

BONE; CHEMORADIOTHERAPY; HEMOGLOBIN; PATIENT MONITORING; PLATELETS; PLATINUM COMPOUNDS; POSITRON EMISSION TOMOGRAPHY;

TOXICITY;

CISPLATIN; FLUORODEOXYGLUCOSE F 18; HEMOGLOBIN;

ADULT; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DOSIMETRY; FEMALE; HEMATOLOGIC DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOCYTE COUNT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INDUCED EMESIS; THROMBOCYTE COUNT; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BONE MARROW; CARCINOMA, ADENOSQUAMOUS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FLUORODEOXYGLUCOSE F18; HEMATOLOGIC DISEASES; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MIDDLE AGED; NEUTROPHILS; PLATELET COUNT; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; UTERINE CERVICAL NEOPLASMS;

EID: 84862665123     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.048     Document Type: Article

References (20)

1. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: A systematic review and meta-analysis. Lancet 2001;358: 781-786.
2. Torres MA, Jhingran A, Thames HD Jr, et al. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys 2008;70: 118-125.
3. Abu-Rustum NR, Lee S, Correa A, et al. Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer. Gynecol Oncol 2001;81:88-91.
4. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-1153.
5. Nugent EK, Case AS, Hoff JT, et al. Chemoradiation in locally advanced cervical carcinoma: An analysis of cisplatin dosing and other clinical prognostic factors. Gynecol Oncol 2010;116: 438-441.
6. Mauch P, Constine L, Greenberger J, et al. Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 1995;31:1319-1339.
7. Mell LK, Kochanski JD, Roeske JC, et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:1356-1365.
8. Rose BS, Aydogan B, Liang Y, et al. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int J Radiat Oncol Biol Phys 2011;79:800-807.
9. Albuquerque K, Giangreco D, Morrison C, et al. Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Int J Radiat Oncol Biol Phys 2011;79:1043-1047.
10. Mell LK, Tiryaki H, Ahn KH, et al. Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer. Int J Radiat Oncol Biol Phys 2008;71:1504-1510.
11. Lujan AE, Mundt AJ, Yamada SD, et al. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:516-521.
12. Blebea JS, Houseni M, Torigian DA, et al. Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. Semin Nucl Med 2007;37:185-194.
13. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
14. Dueñas-González A, Zarbá JJ, Patel F, et al. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with Stage IIB to IVA carcinoma of the cervix. J Clin Oncol 2011;29:1678-1685.
15. Vogler JB 3rd, Murphy WA. Bone marrow imaging. Radiology 1988; 168:679-693.
16. Blomlie V, Rofstad EK, Skjonsberg A, et al. Female pelvic bone marrow: Serial MR imaging before, during, and after radiation therapy. Radiology 1995;194:537-543.
17. Keys HM, Bundy BN, Stehman FB, et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: A randomized trial of the Gynecologic Oncology Group. Gynecol Oncol 2003;89:343-353.
18. Liang Y, Messer K, Rose BS, et al. Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: Principal component analysis on high dimensional data. Int J Radiat Oncol Biol Phys 2010;78:912-919.
19. Roeske JC, Lujan A, Reba RC, et al. Incorporation of SPECT bone marrow imaging into intensity modulated whole-pelvic radiation therapy treatment planning for gynecologic malignancies. Radiother Oncol 2005;77:11-17.
20. Hayman JA, Callahan JW, Herschtal A, et al. Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging. Int J Radiat Oncol Biol Phys 2011;79:847-852.